Chemotherapy-induced peripheral neuropathy; its impact on colorectal cancer patients' lives

Chemotherapy-induced peripheral neuropathy; its impact on colorectal cancer patients' lives - The PROCORE study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43710

Enrollment

800

Registered

2015-06-01

Start date

2016-01-15

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Diagnosed with colorectal cancer - 18 years or older

Exclusion criteria

Exclusion criteria: - Patients with cognitive impairment will not be included because of expected difficulties in completing these questionnaires without assistance. - Patients who are not able to read or write Dutch will be excluded, as they are not able to complete a Dutch questionnaire.

Design outcomes

Primary

Measure	Time frame
Neuropathy, health-related quality of life, disease-specific complaints, depression, fatigue, sleep problems, personality, comorbidity, physical activity, health care utilisation, health supplement use, employment, genetic and biological markers including pro-and anti-inflammatory cytokines (IL-1β, IL-6, TNF-a, IL-RN, and IL-10) genes.	—

Countries

Netherlands

Outcome results